Diabetic Foot Ulcers: Clinical Trials

17 trials for Diabetic Foot Ulcers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 2 terminated, 1 active not recruiting. 17 Phase 2, 8 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 9, Unknown 4, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 18Completed 3, Terminated 2, Unknown 2, Withdrawn 1
Phase 32Completed 1, Unknown 1

Follow Diabetic Foot Ulcers: new trials by email Literature Review of Diabetic Foot Ulcers trials Research Report on Diabetic Foot Ulcers

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
Antimicrobial Peptide PL-5 Topical Spray and Placebo - Diabetic Foot Ulcers
Phase 2Active not recruitingJiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.902024-01-302025-05-25
The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers
PRP-Fibrin Glue, Vitamin E and C, Placebo - Diabetic Foot Ulcers, Diabetic Wound
Phase 2 / Phase 3UnknownMashhad University of Medical Sciences242019-08-282020-03-20
Wound Healing Endpoint and Recurrence
Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound
Phase 1 / Phase 2CompletedSashwati Roy1062019-01-082026-11-18
Evaluation of ABSOLVE in Diabetic Foot Ulcers
RhPDGF-BB, Placebo - Diabetic Foot Ulcers
Phase 2UnknownLynch Biologics LLC402017-01-302017-01-31
Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects
Medical Collagen Membrane with MSC, Medical Collagen Membrane - Wounds, Diabetic Foot Ulcers
Phase 1 / Phase 2UnknownSouth China Research Center for Stem Cell and Regenerative Medicine302016-05-012016-02-03
Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers
Extracorporeal Shockwave Therapy and debridement, debridement and cleaning - Diabetic Foot Ulcers
Phase 1 / Phase 2UnknownHadassah Medical Organization302016-04-012016-02-25
Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients
Selinexor, Standard-of-Care, Vehicle Gel - Diabetic Foot Ulcers
Phase 1 / Phase 2WithdrawnKaryopharm Therapeutics Inc2015-01-012023-01-20
Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers
Gentamicin Topical Gel, Ciprofloxacin, Doxycycline - Diabetic Foot Ulcers
Phase 1 / Phase 2TerminatedRoyer Biomedical, Inc.92014-01-012015-05-14
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
MEBO Wound Ointment (MEBO), Standard of Care - Diabetic Foot Ulcers
Phase 2CompletedSkingenix, Inc.752012-09-012025-11-06
A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
Nexagon® Low Dose, Nexagon® Medium Dose, Nexagon® High Dose - Diabetic Foot Ulcers
Phase 2CompletedOcuNexus Therapeutics, Inc.1682012-07-012014-05-01
Utilization of Platelet Gel for Treatment of Diabetic Foot Ulcers
Platelet Gel, Placebo - Diabetic Foot Ulcers
Phase 1 / Phase 2CompletedRoyan Institute302012-01-012015-12-04
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
MEBO Wound Ointment, Standard of Care (sterile saline moistened gauze) - Diabetic Foot Ulcers
Phase 2CompletedSkingenix, Inc.72010-11-012025-11-06
Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer
Biochaperone PDGF-BB Low dose, Biochaperone PDGF-BB High dose, Regranex - Diabetic Foot Ulcers
Phase 1 / Phase 2CompletedVirchow Group1922010-06-012014-12-15
Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers
Epiflo, Moist Wound Therapy - Diabetic Foot Ulcers
Phase 2 / Phase 3CompletedNeogenix, LLC dba Ogenix1302009-10-012014-05-13
Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers
ATG002 (study drug) - Diabetic Foot Ulcers
Phase 1 / Phase 2TerminatedCoMentis482006-10-012007-08-09
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
Prevention of Diabetic Ulcers - Diabetic Foot Ulcers
Phase 2CompletedUS Department of Veterans Affairs4272000-10-012009-01-21
Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing
Prevention of Pressure Ulcers - Diabetic Foot Ulcers
Phase 2CompletedUS Department of Veterans Affairs1202000-01-012009-02-09

Narrower conditions

Diabetic Foot (17)  ·  Foot Ulcer (5)  ·  Diabetes Mellitus (3)  ·  Wounds and Injuries (3)  ·  Burns (2)  ·  Pressure Ulcer (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Infections (1)  ·  Ulcer (1)  ·  Wound Infection (1)

Broader conditions

Cardiovascular Diseases (17)  ·  Diabetes Complications (17)  ·  Diabetic Angiopathies (17)  ·  Diabetic Neuropathies (17)  ·  Endocrine System Diseases (17)  ·  Leg Ulcer (17)  ·  Skin Diseases (17)  ·  Skin Ulcer (17)  ·  Skin and Connective Tissue Diseases (17)  ·  Vascular Diseases (17)  ·  Diabetes Mellitus (14)  ·  Foot Ulcer (12)  ·  Foot Diseases (5)  ·  Glucose Metabolism Disorders (3)  ·  Metabolic Diseases (3)

Interventions

Standard of Care (3)  ·  Becaplermin (2)  ·  Ciprofloxacin (1)  ·  Debridement (1)  ·  Doxycycline (1)  ·  Drug Evaluation (1)  ·  Extracorporeal Shockwave Therapy (1)  ·  Petroleum (1)  ·  Vitamin E (1)  ·  selinexor (1)

Sponsors

Skingenix, Inc. (2)  ·  US Department of Veterans Affairs (2)  ·  CoMentis (1)  ·  Hadassah Medical Organization (1)  ·  Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. (1)  ·  Karyopharm Therapeutics Inc (1)  ·  Lynch Biologics LLC (1)  ·  Mashhad University of Medical Sciences (1)  ·  Neogenix, LLC dba Ogenix (1)  ·  OcuNexus Therapeutics, Inc. (1)  ·  Royan Institute (1)  ·  Royer Biomedical, Inc. (1)  ·  Sashwati Roy (1)  ·  South China Research Center for Stem Cell and Regenerative Medicine (1)  ·  Virchow Group (1)

Countries

United States (10)  ·  Iran (2)  ·  Guatemala (1)  ·  India (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Ukraine (1)

Top investigators

Robert S Kirsner, MD, PhD (2)  ·  Alireza Goodarzi, MSc (1)  ·  Behnam Molavi, MD (1)  ·  Daryoush Hamidi Alamdari, Ph.D (1)  ·  David G Armstrong, DPM MD PhD (1)  ·  Hamid Gourabi, PhD (1)  ·  Henry Hsu, MD (1)  ·  John Fryer, Ph.D. Asst. Director (1)  ·  Luis Gonzalez, MD (1)  ·  Michael Longaker, MD (1)  ·  Nasser Aghdami, MD,PhD (1)  ·  Sashwati Roy, PhD (1)  ·  Seyedeh Esmat Hosseini, Bs (1)  ·  T C Raghuram, MD, Phd (1)  ·  Vickie R Driver, MSDPM FACFAS (1)

Results publications

PMID 33646060, PMID 34398099